Results 161 to 170 of about 71,425 (202)
Some of the next articles are maybe not open access.
Cardiology Clinics, 1988
Hypertrophic cardiomyopathy is a diverse clinical and pathophysiologic disorder of unknown cause that principally involves the left ventricle and is manifested as asymmetric or concentric hypertrophy. If asymmetric, the hypertrophy is usually greatest in the ventricular septum, but variations occur in which the hypertrophy may be maximal at the mid ...
Z, Sasson, H, Rakowski, E D, Wigle
openaire +2 more sources
Hypertrophic cardiomyopathy is a diverse clinical and pathophysiologic disorder of unknown cause that principally involves the left ventricle and is manifested as asymmetric or concentric hypertrophy. If asymmetric, the hypertrophy is usually greatest in the ventricular septum, but variations occur in which the hypertrophy may be maximal at the mid ...
Z, Sasson, H, Rakowski, E D, Wigle
openaire +2 more sources
Pacing and Clinical Electrophysiology, 2009
Background: Hypertrophic cardiomyopathy (HCM) is one of the most common inherited cardiac disorders, with a prevalence in young adults of one in 500 and is defined by its wall thickening. Methods: This chapter of the supplement will present major clinical impacts of this disorder in its predilection to be inherited; its ...
openaire +2 more sources
Background: Hypertrophic cardiomyopathy (HCM) is one of the most common inherited cardiac disorders, with a prevalence in young adults of one in 500 and is defined by its wall thickening. Methods: This chapter of the supplement will present major clinical impacts of this disorder in its predilection to be inherited; its ...
openaire +2 more sources
Anesthesia & Analgesia, 2015
Hypertrophic cardiomyopathy (HCM) is a relatively common disorder that anesthesiologists encounter among patients in the perioperative period. Fifty years ago, HCM was thought to be an obscure disease. Today, however, our understanding and ability to diagnose patients with HCM have improved dramatically.
Nadia, Hensley +5 more
openaire +2 more sources
Hypertrophic cardiomyopathy (HCM) is a relatively common disorder that anesthesiologists encounter among patients in the perioperative period. Fifty years ago, HCM was thought to be an obscure disease. Today, however, our understanding and ability to diagnose patients with HCM have improved dramatically.
Nadia, Hensley +5 more
openaire +2 more sources
Acta Pharmacologica et Toxicologica, 1986
Abstract: Hypertrophic cardiomyopathy is characterized by a hypertrophic and non‐dilated left ventricle with disproportionate involvement of the intraventricular septum compared to the free walls, and by varying degrees of outflow obstruction during systole. Its symptoms and clinical course, pathogenesis and treatment are briefly discussed.
openaire +2 more sources
Abstract: Hypertrophic cardiomyopathy is characterized by a hypertrophic and non‐dilated left ventricle with disproportionate involvement of the intraventricular septum compared to the free walls, and by varying degrees of outflow obstruction during systole. Its symptoms and clinical course, pathogenesis and treatment are briefly discussed.
openaire +2 more sources
Hypertrophic cardiomyopathy in children
Heart, 2012Hypertrophic cardiomyopathy (HCM) is the second commonest form of heart muscle disease affecting children and adolescents and is a leading cause of sudden death in young athletes. The aetiology of HCM is heterogeneous in the paediatric population, and includes inborn errors of metabolism, neuromuscular disorders and malformation syndromes.
Jeffrey P, Moak, Juan Pablo, Kaski
openaire +2 more sources
Hypertrophic Cardiomyopathy and Pregnancy
Cardiology in ReviewHypertrophic cardiomyopathy (HCM) is an autosomal dominant inherited disease characterized by left ventricular hypertrophy, progressive diastolic dysfunction, left ventricular outflow obstruction, ventricular arrhythmias, and sudden death. Due to widespread screening and early diagnosis, there is a growing number of women of reproductive age with HCM ...
Amha Weldehana +4 more
openaire +2 more sources
Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy
Circulation, 2021Sara Ranjbarvaziri +2 more
exaly
Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy
Circulation, 2021Sara Saberi +2 more
exaly